MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Association of Mitochondrial DNA Haplogroup and pS65-Ub Levels in Lewy Body Disease

N. Tran, X. Hou, M. Heckman, F. Fiesel, S. Koga, D. Dickson, W. Springer, O. Ross (Jacksonville, USA)

Meeting: 2025 International Congress

Keywords: Dementia with Lewy bodies (DLB), Mitochondrial DNA(mtDNA)

Category: Parkinson's Disease: Genetics

Objective: To determine whether specific mitochondrial DNA (mtDNA) haplogroup(s) affect the level of p-S65-Ub as quantitative marker of mitochondrial damage in Lewy Body Disease.

Background: Perturbations in lipid homeostasis, mitochondrial dysfunction, and lysosomal impairment have been indicated as the most prominent biological pathways contributing to LBD. During stress, PINK-PRKN label damaged mitochondria with phosphorylated Ub (pS65-Ub). Emerging evidence suggests that mitochondrial DNA variations also exhibit unique oxidative phosphorylation capacity, generation of reactive oxygen species, and thus overall disease susceptibility. However, the contribution of mtDNA variation to mitochondrial damage in LBD remains unknown.

Method: A total of 514 LBD cases from the brain bank for neurodegenerative disorders at the Mayo Clinic in Jacksonville, Florida were included in this study. Information was collected regarding age at death, sex, LBD subtype, Braak stage, Thal phase, pS65-Ub level in the hippocampus. All subjects were Caucasian, non-Hispanic, and unrelated. We also generated whole-genome sequencing data for the same 514 samples from the cerebellum. The mitochondrial DNA variations were extracted directly from the sequencing data results using Mitochondrial High-Performance Caller (MitoHPC). The association of each separate mitochondrial haplogroup with pS65-Ub level was evaluated using a linear regression model that was adjusted for age at death and sex, and where pS65-Ub level was assessed on the natural logarithm scale owing to its skewed distribution. Haplogroups that occurred in fewer than five subjects were summarized descriptively but were not included in association analysis.

Results: There was a significant association between presence of haplogroup V and a lower pS65-Ub level (β: -0.66, P=0.022). Additionally, though not quite significant, there was a trend toward an association between presence of haplogroup W and an increased pS65-Ub level (β: 0.65, P=0.085). No other notable associations between haplogroups and pS65-Ub were observed (all P≥0.24).

Conclusion: Our study highlights a strong association between mitochondrial DNA haplogroup V and p-S65-Ub. We are currently conducting a replication cohort study to validate these findings. To our knowledge, this is the first study to characterize the link between mtDNA haplogroup and pS65-Ub as a quantitative marker of mitochondrial quality control in LBD.

To cite this abstract in AMA style:

N. Tran, X. Hou, M. Heckman, F. Fiesel, S. Koga, D. Dickson, W. Springer, O. Ross. Association of Mitochondrial DNA Haplogroup and pS65-Ub Levels in Lewy Body Disease [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/association-of-mitochondrial-dna-haplogroup-and-ps65-ub-levels-in-lewy-body-disease/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/association-of-mitochondrial-dna-haplogroup-and-ps65-ub-levels-in-lewy-body-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley